SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001753926-23-001529
Filing Date
2023-11-22
Accepted
2023-11-22 16:05:48
Documents
12
Period of Report
2023-11-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K g083865_8k.htm   iXBRL 8-K 32288
  Complete submission text file 0001753926-23-001529.txt   207461

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lipo-20231122.xsd EX-101.SCH 3012
3 XBRL LABEL FILE lipo-20231122_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lipo-20231122_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT g083865_8k_htm.xml XML 3425
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 231433432
SIC: 2834 Pharmaceutical Preparations